![](http://www.bio-cancer.com/wordpress/wp-content/uploads/2019/12/BCT-100_small.jpg)
BCT-100
Pegylated recombinant human arginase 1, is a urea cycle enzyme of 329 amino acid residues. It is being developed for arginine depletion therapy in arginine auxotrophic cancers and multiple autoimmune disorders.
BCT-200
BCT-200 is modified from BCT-100 to maximize drug stability and safety.